I don't think that route could (or should) work. Unless the company is in fact actively (if subtly) endorsing the off-label use (for instance, by distributing articles that promote such use).
Informative discussion of some of the issues here: https://www.nejm.org/doi/full/10.1056/NEJMp0802107
I don't think that route could (or should) work. Unless the company is in fact actively (if subtly) endorsing the off-label use (for instance, by distributing articles that promote such use).
I don't think that route could (or should) work. Unless the company is in fact actively (if subtly) endorsing the off-label use (for instance, by distributing articles that promote such use).
Informative discussion of some of the issues here: https://www.nejm.org/doi/full/10.1056/NEJMp0802107
It would be interesting to know if the drug companies are doing any marketing, especially indirectly through sponsored social media content.